Didier Meulendijks

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Top Venues

Future oncology (London, England)

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Paul-Michael Agapow, Rob Mulla, Natasha Markuzon, Lone H Ottesen, Didier Meulendijks
Systematic review of time to subsequent therapy as a candidate surrogate endpoint in advanced solid tumors. Future oncology (London, England) (2023)
Marc Maliepaard, Timi Toiviainen, Marie Louise De Bruin, Didier Meulendijks
Pharmacogenetic-Pharmacokinetic Interactions in Drug Marketing Authorization Applications via the European Medicines Agency Between 2014 and 2017. Clinical pharmacology and therapeutics 108 (2) (2020)